The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

With the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

This recommendation only applies to those adults who did not get vaccinated with an RSV shot last year. Before 2023, there were no approved vaccines against RSV infections anywhere in the world.

About 20% of New Yorkers ages 60 and older took the RSV shot. Now CDC updated recommendations. What you should know ...

Today’s updated recommendation is based on analyses of RSV disease burden among people 60 and older, as well as RSV vaccine effectiveness and cost-effectiveness studies, according to the CDC.

The CDC has updated its recommendations for adults ages 60 and older about getting the RSV vaccine. Adults 75 and older and high risk 60-74-year-olds should get the RSV vaccine, according to ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the use of respiratory syncytial virus vaccines in adults aged between 50 and 59 ...